Resolving an unmet clinical/operational need in Ophthalmology
Posted on 28th May, 2019
A Tiny Implant
A Huge Impact
iStent inject® is one of the smallest medical implants known to be implanted in the human body and can effectively lower IOP, one of the most important risk factors for glaucoma.
Implanted at the time of cataract surgery or as a stand-alone procedure, iStent inject® can help to restore your eye’s natural fluid outflow and is designed to reduce pressure inside your eye and, at the discretion of an eye doctor, may reduce your reliance on glaucoma medication.
The treatment for glaucoma has come a long way. Today’s advanced technologies and procedures make it possible to diagnose and successfully manage this progressive disease. The overall goal of treatment has always remained the same — reducing intraocular pressure (IOP) and glaucomatous progression.
A Revolution in Glaucoma Therapy
With the development of trabecular micro-bypass technologies, such as iStent inject®, it is becoming a preferred approach to glaucoma management for many eye doctors and their patients with open-angle glaucoma.
How iStent inject® Works
To help control the increased pressure in your eye associated with glaucoma, iStent inject® creates a bypass between the front part of your eye and its natural drainage pathway to increase the flow of fluid. iStent inject® is designed to:
• Improve your eye’s natural outflow to safely lower intraocular pressure• Work continuously to improve the natural flow of fluid in your eyes
Benefits associated with this innovative treatment include:
• Minimally traumatic to delicate eye tissue• Effectively lowers IOP• Excellent safety profile
- To engage with NHS stakeholders working in Ophthalmology